Cargando…
Clinical evaluation of switching from immediate‐release to prolonged‐release lithium in bipolar patients, poorly tolerant to lithium immediate‐release treatment: A randomized clinical trial
AIM: The effect of switching from lithium immediate release (Li‐IR) to lithium prolonged release (Li‐PR) on lithium‐induced tremor after 1 and 12 weeks of treatment was evaluated in a randomized, multicenter, open trial, in bipolar patients from the participating sites with a tremor severity ≥2 (Udv...
Autores principales: | , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8933786/ https://www.ncbi.nlm.nih.gov/pubmed/35137572 http://dx.doi.org/10.1002/brb3.2485 |
_version_ | 1784671732955611136 |
---|---|
author | Pelacchi, Federica Dell'Osso, Liliana Bondi, Emi Amore, Mario Fagiolini, Andrea Iazzetta, Paolo Pierucci, Daniela Gorini, Manuela Quarchioni, Elisa Comandini, Alessandro Salvatori, Enrica Cattaneo, Agnese Pompili, Maurizio |
author_facet | Pelacchi, Federica Dell'Osso, Liliana Bondi, Emi Amore, Mario Fagiolini, Andrea Iazzetta, Paolo Pierucci, Daniela Gorini, Manuela Quarchioni, Elisa Comandini, Alessandro Salvatori, Enrica Cattaneo, Agnese Pompili, Maurizio |
author_sort | Pelacchi, Federica |
collection | PubMed |
description | AIM: The effect of switching from lithium immediate release (Li‐IR) to lithium prolonged release (Li‐PR) on lithium‐induced tremor after 1 and 12 weeks of treatment was evaluated in a randomized, multicenter, open trial, in bipolar patients from the participating sites with a tremor severity ≥2 (Udvalg for Kliniske Undersøgelser [UKU] rating scale) despite optimal lithium titration. METHODS: The primary endpoint was the evaluation of tremor by means of the UKU scale after 1 week of treatment. Secondary endpoints included manic Young Mania Rating Scale (YMRS) and depressive symptoms (Montgomery–Asberg Depression Rating Scale), a global assessment of the patient's status (Clinical Global Impression), polyuria/polydipsia (UKU item 3.8) and patient‐reported outcomes. RESULTS: Owing to difficulties in including suitable patients the enrollment phase was closed when 73 patients were randomized. Notwithstanding the lower number of patients, in the modified intention‐to‐treat population (n = 70) the primary endpoint was statistically significant: tremor improved after 1 week in 62.9% in Li‐PR group against 20.0% of patients in Li‐IR group (p = .0006; two‐tailed Fisher's exact test). The difference remained statistically significant after 4 (p = .0031) and 12 weeks (p = .0128). The same analysis performed in the PP population confirmed these results. Among the secondary endpoints, only the factor convenience of the treatment satisfaction questionnaire showed a statistically significant difference between groups. There were no apparent differences in the safety profile of the two formulations. CONCLUSIONS: This study is the first comparative documentation of a potential benefit of the prolonged‐release formulation in reducing the symptom tremor, a well‐known adverse effect of lithium therapy. Indeed, the study results should be interpreted taking into account the sample size lower than planned. |
format | Online Article Text |
id | pubmed-8933786 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | John Wiley and Sons Inc. |
record_format | MEDLINE/PubMed |
spelling | pubmed-89337862022-03-24 Clinical evaluation of switching from immediate‐release to prolonged‐release lithium in bipolar patients, poorly tolerant to lithium immediate‐release treatment: A randomized clinical trial Pelacchi, Federica Dell'Osso, Liliana Bondi, Emi Amore, Mario Fagiolini, Andrea Iazzetta, Paolo Pierucci, Daniela Gorini, Manuela Quarchioni, Elisa Comandini, Alessandro Salvatori, Enrica Cattaneo, Agnese Pompili, Maurizio Brain Behav Registered Report Stage 2 AIM: The effect of switching from lithium immediate release (Li‐IR) to lithium prolonged release (Li‐PR) on lithium‐induced tremor after 1 and 12 weeks of treatment was evaluated in a randomized, multicenter, open trial, in bipolar patients from the participating sites with a tremor severity ≥2 (Udvalg for Kliniske Undersøgelser [UKU] rating scale) despite optimal lithium titration. METHODS: The primary endpoint was the evaluation of tremor by means of the UKU scale after 1 week of treatment. Secondary endpoints included manic Young Mania Rating Scale (YMRS) and depressive symptoms (Montgomery–Asberg Depression Rating Scale), a global assessment of the patient's status (Clinical Global Impression), polyuria/polydipsia (UKU item 3.8) and patient‐reported outcomes. RESULTS: Owing to difficulties in including suitable patients the enrollment phase was closed when 73 patients were randomized. Notwithstanding the lower number of patients, in the modified intention‐to‐treat population (n = 70) the primary endpoint was statistically significant: tremor improved after 1 week in 62.9% in Li‐PR group against 20.0% of patients in Li‐IR group (p = .0006; two‐tailed Fisher's exact test). The difference remained statistically significant after 4 (p = .0031) and 12 weeks (p = .0128). The same analysis performed in the PP population confirmed these results. Among the secondary endpoints, only the factor convenience of the treatment satisfaction questionnaire showed a statistically significant difference between groups. There were no apparent differences in the safety profile of the two formulations. CONCLUSIONS: This study is the first comparative documentation of a potential benefit of the prolonged‐release formulation in reducing the symptom tremor, a well‐known adverse effect of lithium therapy. Indeed, the study results should be interpreted taking into account the sample size lower than planned. John Wiley and Sons Inc. 2022-02-09 /pmc/articles/PMC8933786/ /pubmed/35137572 http://dx.doi.org/10.1002/brb3.2485 Text en © 2022 The Authors. Brain and Behavior published by Wiley Periodicals LLC https://creativecommons.org/licenses/by/4.0/This is an open access article under the terms of the http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Registered Report Stage 2 Pelacchi, Federica Dell'Osso, Liliana Bondi, Emi Amore, Mario Fagiolini, Andrea Iazzetta, Paolo Pierucci, Daniela Gorini, Manuela Quarchioni, Elisa Comandini, Alessandro Salvatori, Enrica Cattaneo, Agnese Pompili, Maurizio Clinical evaluation of switching from immediate‐release to prolonged‐release lithium in bipolar patients, poorly tolerant to lithium immediate‐release treatment: A randomized clinical trial |
title | Clinical evaluation of switching from immediate‐release to prolonged‐release lithium in bipolar patients, poorly tolerant to lithium immediate‐release treatment: A randomized clinical trial |
title_full | Clinical evaluation of switching from immediate‐release to prolonged‐release lithium in bipolar patients, poorly tolerant to lithium immediate‐release treatment: A randomized clinical trial |
title_fullStr | Clinical evaluation of switching from immediate‐release to prolonged‐release lithium in bipolar patients, poorly tolerant to lithium immediate‐release treatment: A randomized clinical trial |
title_full_unstemmed | Clinical evaluation of switching from immediate‐release to prolonged‐release lithium in bipolar patients, poorly tolerant to lithium immediate‐release treatment: A randomized clinical trial |
title_short | Clinical evaluation of switching from immediate‐release to prolonged‐release lithium in bipolar patients, poorly tolerant to lithium immediate‐release treatment: A randomized clinical trial |
title_sort | clinical evaluation of switching from immediate‐release to prolonged‐release lithium in bipolar patients, poorly tolerant to lithium immediate‐release treatment: a randomized clinical trial |
topic | Registered Report Stage 2 |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8933786/ https://www.ncbi.nlm.nih.gov/pubmed/35137572 http://dx.doi.org/10.1002/brb3.2485 |
work_keys_str_mv | AT pelacchifederica clinicalevaluationofswitchingfromimmediatereleasetoprolongedreleaselithiuminbipolarpatientspoorlytoleranttolithiumimmediatereleasetreatmentarandomizedclinicaltrial AT dellossoliliana clinicalevaluationofswitchingfromimmediatereleasetoprolongedreleaselithiuminbipolarpatientspoorlytoleranttolithiumimmediatereleasetreatmentarandomizedclinicaltrial AT bondiemi clinicalevaluationofswitchingfromimmediatereleasetoprolongedreleaselithiuminbipolarpatientspoorlytoleranttolithiumimmediatereleasetreatmentarandomizedclinicaltrial AT amoremario clinicalevaluationofswitchingfromimmediatereleasetoprolongedreleaselithiuminbipolarpatientspoorlytoleranttolithiumimmediatereleasetreatmentarandomizedclinicaltrial AT fagioliniandrea clinicalevaluationofswitchingfromimmediatereleasetoprolongedreleaselithiuminbipolarpatientspoorlytoleranttolithiumimmediatereleasetreatmentarandomizedclinicaltrial AT iazzettapaolo clinicalevaluationofswitchingfromimmediatereleasetoprolongedreleaselithiuminbipolarpatientspoorlytoleranttolithiumimmediatereleasetreatmentarandomizedclinicaltrial AT pieruccidaniela clinicalevaluationofswitchingfromimmediatereleasetoprolongedreleaselithiuminbipolarpatientspoorlytoleranttolithiumimmediatereleasetreatmentarandomizedclinicaltrial AT gorinimanuela clinicalevaluationofswitchingfromimmediatereleasetoprolongedreleaselithiuminbipolarpatientspoorlytoleranttolithiumimmediatereleasetreatmentarandomizedclinicaltrial AT quarchionielisa clinicalevaluationofswitchingfromimmediatereleasetoprolongedreleaselithiuminbipolarpatientspoorlytoleranttolithiumimmediatereleasetreatmentarandomizedclinicaltrial AT comandinialessandro clinicalevaluationofswitchingfromimmediatereleasetoprolongedreleaselithiuminbipolarpatientspoorlytoleranttolithiumimmediatereleasetreatmentarandomizedclinicaltrial AT salvatorienrica clinicalevaluationofswitchingfromimmediatereleasetoprolongedreleaselithiuminbipolarpatientspoorlytoleranttolithiumimmediatereleasetreatmentarandomizedclinicaltrial AT cattaneoagnese clinicalevaluationofswitchingfromimmediatereleasetoprolongedreleaselithiuminbipolarpatientspoorlytoleranttolithiumimmediatereleasetreatmentarandomizedclinicaltrial AT pompilimaurizio clinicalevaluationofswitchingfromimmediatereleasetoprolongedreleaselithiuminbipolarpatientspoorlytoleranttolithiumimmediatereleasetreatmentarandomizedclinicaltrial AT clinicalevaluationofswitchingfromimmediatereleasetoprolongedreleaselithiuminbipolarpatientspoorlytoleranttolithiumimmediatereleasetreatmentarandomizedclinicaltrial |